Lifecome Biochemistry Co.,Ltd. announced a private placement to issue not more than 46,624,751 A shares pre-plan for gross proceeds of not more than CNY 1,300,000,000 on June 21, 2023. The transaction included participation from not more than 35 investors. The issue price cannot be less than 80% of the average price in the 20 trading days before the pricing reference date.

The shares issued cannot be transferred within 6 months from the issuance closing date. The transaction has been approved at the 30th (extraordinary) meeting of the company’s 4th directorate and is subject to the approvals of the company’s shareholders, the Shenzhen Stock Exchange, and the China Securities Regulatory Commission.